NASDAQ : DTIL

Precision BioSciences, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 7.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 205.36M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Precision BioSciences, Inc. (DTIL) reported revenue of 45.05M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue45.05M34.26M68.70M48.73M25.10M115.53M
Gross Profit45.05M34.26M68.70M48.73M25.10M115.53M
Selling, General & Admin28.13M32.24M35.30M39.09M43.34M43.23M
Research & Development53.32M54.17M59.56M53.38M44.07M111.68M
Operating Expenses81.45M86.41M94.86M92.46M87.41M154.91M
Operating Income-36.40M-52.15M-26.16M-43.74M-62.31M-39.38M
Interest Expense-1.32M-1.42M-1.78M-2.23M-1.11M-132.00K
Interest & Investment Income3.74M4.24M6.76M7.69M3.47M208.00K
Earnings From Equity Investments-5.96M-5.28M-1.08M-4.93M-1.58M184.00K
Other Non Operating Income (Expenses)-9.82M11.13M29.61M
EBT Excluding Unusual Items-49.75M-43.49M7.34M-43.21M-61.52M-39.12M
Gain (Loss) on Sale of Investments-3.45M-2.67M258.00K1.15M-510.00K2.56M
Gain (Loss) on Sale of Assets-382.00K-421.00K-436.00K-461.00K-30.00K5.96M
Asset Writedown-36.00K-36.00K-10.84M
Pretax Income-53.62M-46.61M7.17M-42.53M-72.91M-30.60M
Earnings From Continuing Operations-53.62M-46.61M7.17M-42.53M-72.91M-30.60M
Earnings From Discontinued Operations885.00K885.00K-18.79M-38.73M
Net Income-52.73M-45.72M7.17M-61.32M-111.64M-30.60M
Net Income to Common-52.73M-45.72M7.17M-61.32M-111.64M-30.60M
Shares Outstanding (Basic)20.36M12.83M6.83M3.84M2.93M1.96M
Shares Outstanding (Diluted)20.36M12.83M6.88M3.84M2.93M1.96M
EPS (Basic)-2.59-3.561.05-15.96-38.10-15.64
EPS (Diluted)-2.59-3.561.04-15.96-38.10-15.64
Free Cash Flow-51.94M-65.93M-58.70M-86.07M-49.07M-15.91M
Free Cash Flow Per Share-2.55-5.14-8.53-22.41-16.75-8.13
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin-80.78%-152.19%-38.08%-89.76%-248.26%-34.08%
Profit Margin-117.04%-133.45%10.43%-125.84%-444.80%-26.49%
Free Cash Flow Margin-115.27%-192.41%-85.44%-176.64%-195.52%-13.77%
EBITDA-35.15M-50.68M-22.76M-36.92M-54.51M-30.39M
EBITDA Margin-78.01%-147.91%-33.13%-75.77%-217.19%-26.31%
D&A For EBITDA1.25M1.47M3.40M6.82M7.80M8.98M
EBIT-36.40M-52.15M-26.16M-43.74M-62.31M-39.38M
EBIT Margin-80.78%-152.19%-38.08%-89.76%-248.26%-34.08%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents86.08M110.82M85.90M116.68M189.58M143.66M
Short-Term Investments1.47M4.76M413.00K
Cash & Short-Term Investments87.55M115.58M86.31M116.68M189.58M143.66M
Accounts Receivable1.70M901.00K720.00K488.00K
Receivables1.70M12.80M720.00K488.00K
Prepaid Expenses4.00M3.11M6.44M5.98M6.03M17.43M
Other Current Assets5.00K45.00K538.00K906.00K2.78M169.00K
Total Current Assets91.55M118.74M94.99M136.36M199.10M161.75M
Property, Plant & Equipment6.08M7.23M10.18M14.60M13.78M29.33M
Long-Term Investments744.00K744.00K3.21M3.21M4.75M6.84M
Other Intangible Assets1.09M1.17M622.00K400.00K731.00K2.05M
Other Long-Term Assets26.46M26.54M22.79M225.00K12.57M4.64M
Total Assets125.92M154.42M136.39M159.78M238.17M211.50M
Accounts Payable828.00K296.00K1.31M2.97M653.00K1.14M
Accrued Expenses4.12M6.46M7.20M6.54M6.93M10.79M
Short-Term Debt22.41M
Current Portion of Leases1.61M1.51M1.32M1.13M1.68M1.82M
Current Unearned Revenue2.96M12.04M46.19M21.24M
Other Current Liabilities588.00K649.00K2.19M4.90M4.21M977.00K
Total Current Liabilities7.14M8.91M14.98M49.99M59.66M35.98M
Long-Term Debt22.42M22.40M22.32M22.22M2.48M
Long-Term Leases4.07M4.90M6.40M7.72M1.06M4.81M
Long-Term Unearned Revenue10.00M10.00M33.30M83.08M92.87M77.02M
Other Long-Term Liabilities36.99M15.95M2.99M128.00K1.92M44.00K
Total Liabilities80.63M62.17M80.00M140.92M177.74M120.33M
Common Stock1.00K1.00K1.00K1.00K1.00K
Additional Paid-In Capital625.52M621.39M539.81M509.44M489.70M408.80M
Retained Earnings-579.28M-528.19M-482.46M-489.63M-428.31M-316.68M
Treasury Stock-952.00K-952.00K-952.00K-952.00K-952.00K-952.00K
Total Common Equity45.29M92.25M56.39M18.86M60.43M91.17M
Shareholders' Equity45.29M92.25M56.39M18.86M60.43M91.17M
Total Liabilities & Equity125.92M154.42M136.39M159.78M238.17M211.50M
Total Debt28.10M28.81M30.05M31.27M24.96M9.11M
Net Cash (Debt)59.45M86.78M56.27M85.41M164.62M134.55M
Net Cash Per Share2.926.778.1722.2356.1968.78
Filing Date Shares Outstanding27.60M24.73M10.48M6.92M3.71M2.03M
Total Common Shares Outstanding26.43M24.09M8.20M4.16M3.70M2.03M
Working Capital84.41M109.83M80.01M86.37M139.44M125.77M
Book Value Per Share1.713.836.874.5316.3444.91
Tangible Book Value44.20M91.08M55.77M18.46M59.70M89.12M
Tangible Book Value Per Share1.673.786.804.4316.1443.90
Machinery17.62M18.70M19.38M20.78M22.93M
Construction In Progress9.00K70.00K520.00K3.04M
Leasehold Improvements12.06M12.03M11.95M11.95M22.78M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-52.73M-45.72M7.17M-61.32M-111.64M-30.60M
Depreciation & Amortization2.60M2.75M4.58M8.26M9.00M10.20M
Loss (Gain) From Sale of Assets-473.00K-434.00K436.00K563.00K106.00K-5.96M
Asset Writedown & Restructuring Costs36.00K36.00K11.44M-2.56M
Loss (Gain) From Sale of Investments3.45M2.67M-258.00K-1.15M510.00K
Loss (Gain) on Equity Investments5.96M5.28M1.08M4.93M1.58M-184.00K
Stock-Based Compensation7.82M10.19M12.60M14.04M19.20M16.51M
Other Operating Activities10.00M-11.37M-30.06M-147.00K-60.00K-17.85M
Change in Accounts Receivable1.70M-797.00K-181.00K-232.00K9.51M
Change in Accounts Payable-304.00K-737.00K-2.10M1.51M153.00K867.00K
Change in Unearned Revenue-26.21M-26.26M-58.86M-43.95M27.36M6.84M
Change in Other Net Operating Assets-2.04M-3.95M7.75M1.13M-3.17M2.37M
Operating Cash Flow-51.90M-65.84M-58.45M-84.11M-45.75M-10.85M
Capital Expenditures-37.00K-85.00K-250.00K-1.96M-3.32M-5.05M
Sale of Property, Plant & Equipment66.00K66.00K60.00K107.00K
Sale (Purchase) of Intangibles-450.00K-615.00K-25.00K-321.00K-750.00K
Other Investing Activities8.00M
Investing Cash Flow-421.00K-634.00K-215.00K5.83M-3.32M-5.80M
Long-Term Debt Issued22.47M19.80M4.97M
Total Debt Issued22.47M19.80M4.97M
Long-Term Debt Repaid-22.50M-2.50M
Net Debt Issued (Repaid)-37.00K19.80M2.47M
Issuance of Common Stock79.92M95.16M50.49M5.39M75.18M68.06M
Other Financing Activities-13.00K
Financing Cash Flow79.92M95.16M50.45M5.39M94.98M70.52M
Net Cash Flow27.60M28.68M-8.21M-72.90M45.91M53.87M
Free Cash Flow-51.94M-65.93M-58.70M-86.07M-49.07M-15.91M
Free Cash Flow Margin-115.27%-192.41%-85.44%-176.64%-195.52%-13.77%
Free Cash Flow Per Share-2.55-5.14-8.53-22.41-16.75-8.13
Levered Free Cash Flow-16.25M-21.97M-2.34M-50.41M17.64M-12.85M
Unlevered Free Cash Flow-15.43M-21.09M-1.22M-49.01M18.33M-12.77M
Cash Interest Paid1.27M1.35M1.74M2.02M824.00K68.00K
Change in Working Capital-28.55M-29.24M-54.00M-41.49M24.11M19.58M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization194.87M100.14M29.23M44.50M132.04M449.68M
Enterprise Value135.42M84.40M-41.67M-53.87M-52.55M300.75M
Last Close Price7.064.163.8110.9535.70222.00
PE Ratio4.08
PS Ratio4.332.920.420.915.263.89
PB Ratio4.121.090.522.362.194.93
P/TBV Ratio4.411.100.522.412.215.05
EV/Sales Ratio3.012.462.60
Debt / Equity Ratio0.620.310.531.660.410.10
Net Debt / Equity Ratio-1.31-0.94-1.00-4.53-2.72-1.48
Net Debt / EBITDA Ratio1.691.712.472.313.024.43
Net Debt / FCF Ratio1.151.320.960.993.358.46
Asset Turnover0.380.240.460.240.110.64
Quick Ratio12.2612.975.882.353.194.01
Current Ratio12.8213.326.342.733.344.50
Return on Equity (ROE)-135.15%-62.71%19.05%-107.26%-96.19%-45.14%
Return on Assets (ROA)-19.37%-22.41%-11.04%-13.74%-17.32%-13.61%
Return on Capital Employed (ROCE)-30.60%-35.80%-21.50%-39.80%-34.90%-22.40%
Earnings Yield-36.68%-45.66%24.52%-137.79%-84.55%-6.80%
FCF Yield-26.65%-65.84%-200.83%-193.42%-37.16%-3.54%
Buyback Yield / Dilution-128.47%-86.32%-79.20%-31.11%-49.77%-12.79%